Phase Solubility Studies of Poorly Soluble Drug Molecules by Using O-Phosphorylated Calixarenes as Drug-Solubilizing Agents Bayrakcı, M.; Ertul, Ş.; Yilmaz, M.; Journal of Chemical & Engineering Data 2012, 57, 233-239
- Journal: Journal of Chemical & Engineering Data
- Sample Quantity(ies): Molality
- Methodology: HPLC
- Phase(s): Liquid
- Substances:
- water H2O (XLYOFNOQVPJJNP-UHFFFAOYSA-N) - Commercial source
- dimethyl 4-(2-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate C17H18N2O6 (HYIMSNHJOBLJNT-UHFFFAOYSA-N) - Commercial source
- tetrasodium 1(5),3(5),5(5),7(5)-tetra-tert-butyl-1,3,5,7(1,3)-tetrabenzenacyclooctaphane-1(2),3(2),5(2),7(2)-tetrayl tetrakis(hydrogen phosphate) C44H56Na4O16P4 (YFYLECXBKWHJDI-UHFFFAOYSA-J) - Synthesized by the authors
Data
| m (mol kg-1) | m (mol kg-1) |
| 0.001 | 5.92 |
| 0.003 | 7.87 |
| 0.005 | 9.52 |
| 0.007 | 11.2 |
21717; water + dimethyl 4-(2-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate + tetrasodium 1(5),3(5),5(5),7(5)-tetra-tert-butyl-1,3,5,7(1,3)-tetrabenzenacyclooctaphane-1(2),3(2),5(2),7(2)-tetrayl tetrakis(hydrogen phosphate); 00004:00676:04138